Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential relationship between the Voluntary Scheme for Branded Medicines Pricing Access and the delivery of the ambitions set out in the Life Sciences Vision; and if he will make a statement.

No specific assessment has been made. However, the Government remains committed to working with the pharmaceutical industry to deliver on the commitments made in the Life Sciences Vision and to ensure that the Voluntary Scheme for Branded Medicines Pricing and Access is seen as part of a holistic environment for Life Sciences.